Caris Life Sciences (CAI) Interest Expenses (2024 - 2026)

Caris Life Sciences has reported Interest Expenses for 3 years, with the latest figure at $9.2 million in Q2 2026.

• On a quarterly basis, Interest Expenses fell 51.96% year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $46.9 million, a 20.58% decrease from a year earlier, with the FY2025 full-year figure at $56.9 million, up 13.65% from the prior year.
• Interest Expenses was $9.2 million for Q2 2026 at Caris Life Sciences, down from $12.8 million in the prior quarter.
• The five-year high for Interest Expenses was $19.2 million in Q2 2025, with the low at $9.2 million in Q2 2026.
• Average Interest Expenses over 3 years is $13.3 million, with a median of $13.3 million recorded in 2024.
• The sharpest annual moves came in 2025 and 2026: Interest Expenses jumped 40.47% in 2025, then plunged 51.96% in 2026.
• Over 3 years, Interest Expenses stood at $13.3 million in 2024, then fell by 14.37% to $11.4 million in 2025, then fell by 18.74% to $9.2 million in 2026.
• The last three Interest Expenses figures came in at $9.2 million (Q2 2026), $12.8 million (Q1 2026), and $11.4 million (Q4 2025), per Business Quant data.